Literature DB >> 4166088

The effect of alpha-2-macroglobulin in human serum on trypsin, plasmin, and thrombin activities.

K James, F B Taylor, H H Fudenberg.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 4166088     DOI: 10.1016/0005-2795(67)90080-3

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


× No keyword cloud information.
  9 in total

1.  Targeting of plasminogen activator inhibitor 1 improves fibrinolytic therapy for tetracycline-induced pleural injury in rabbits.

Authors:  Galina Florova; Ali Azghani; Sophia Karandashova; Chris Schaefer; Kathleen Koenig; Kris Stewart-Evans; Paul J Declerck; Steven Idell; Andrey A Komissarov
Journal:  Am J Respir Cell Mol Biol       Date:  2015-04       Impact factor: 6.914

Review 2.  [Intracellular proteolysis].

Authors:  P Bohley
Journal:  Naturwissenschaften       Date:  1968-05

3.  The inhibitory effect of alpha-2-macroglobulin on tumor growth.

Authors:  M von Ardenne; R A Chaplain
Journal:  Experientia       Date:  1973-10-15

4.  Clinical experience with brinase.

Authors:  E P Frisch
Journal:  J Clin Pathol       Date:  1972-07       Impact factor: 3.411

5.  Alpha1-antitrypsin and alpha2-macroglobulin in newborn infants. II. Relation to the coagulation system.

Authors:  U Göbel; A Triebel; C Petrich; H von Voss
Journal:  Eur J Pediatr       Date:  1978-09-08       Impact factor: 3.183

6.  Interaction of alpha 2-macroglobulin with L-asparaginase.

Authors:  E Soru
Journal:  Mol Cell Biochem       Date:  1979-02-09       Impact factor: 3.396

Review 7.  Continuing education course #2: current understanding of hemostasis.

Authors:  Andrew J Gale
Journal:  Toxicol Pathol       Date:  2010-11-30       Impact factor: 1.902

8.  Host plasma proteins on the surface of pathogenic Trichomonas vaginalis.

Authors:  K M Peterson; J F Alderete
Journal:  Infect Immun       Date:  1982-08       Impact factor: 3.441

9.  Human plasma alpha 2-macroglobulin. An inhibitor of plasma kallikrein.

Authors:  P C Harpel
Journal:  J Exp Med       Date:  1970-08-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.